VALUPAK SHOECOVERS, NON-COND 4831

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00 report with the FDA on 2000-08-18 for VALUPAK SHOECOVERS, NON-COND 4831 manufactured by Allegiance Healthcare Corp..

Event Text Entries

[187143] Plaintiff, while wearing shoe covers, lost traction slipped and fell in the gowning room adjacent to the operating room at the hosp. No specific injuries are described.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1423507-2000-00212
MDR Report Key291409
Report Source00
Date Received2000-08-18
Date of Report2000-08-18
Date of Event1997-08-18
Date Mfgr Received2000-08-15
Date Added to Maude2000-08-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationATTORNEY
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactPATRICIA SHARPE-GREGG
Manufacturer Street1500 WAUKEGAN RD.
Manufacturer CityMCGAW PARK IL 60085
Manufacturer CountryUS
Manufacturer Postal60085
Manufacturer Phone8475783636
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVALUPAK SHOECOVERS, NON-COND
Generic NameVALUPAK SHOECOVERS, NON-COND
Product CodeFXP
Date Received2000-08-18
Model Number4831
Catalog Number4831
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key282037
ManufacturerALLEGIANCE HEALTHCARE CORP.
Manufacturer Address1500 WAUKEGAN RD. MCGAW PARK IL 60085 US
Baseline Brand NameVALUPAK SHOECOVERS, NON-COND
Baseline Generic NameSHOECOVERS, NON-COND
Baseline Model No4831
Baseline Catalog No4831
Baseline IDNA
Baseline Device FamilyAPPAREL
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK800528
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2000-08-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.